Literature DB >> 28373354

Protective Role for Macrophages in Respiratory Francisella tularensis Infection.

Donald J Steiner1, Yoichi Furuya1, Michael B Jordan2,3, Dennis W Metzger4.   

Abstract

Francisella tularensis causes lethal pneumonia following infection of the lungs by targeting macrophages for intracellular replication; however, macrophages stimulated with interferon gamma (IFN-γ) can resist infection in vitro We therefore hypothesized that the protective effect of IFN-γ against F. tularensisin vivo requires macrophages receptive to stimulation. We found that the lethality of pulmonary F. tularensis LVS infection was exacerbated under conditions of alveolar macrophage depletion and in mice with a macrophage-specific defect in IFN-γ signaling (termed mice with macrophages insensitive to IFN-γ [MIIG mice]). We previously found that treatment with exogenous interleukin 12 (IL-12) protects against F. tularensis infection; this protection was lost in MIIG mice. MIIG mice also exhibited reduced neutrophil recruitment to the lungs following infection. Systemic neutrophil depletion was found to render wild-type mice highly sensitive to respiratory F. tularensis infection, and depletion beginning at 3 days postinfection led to more pronounced sensitivity than depletion beginning prior to infection. Furthermore, IL-12-mediated protection required NADPH oxidase activity. These results indicate that lung macrophages serve a critical protective role in respiratory F. tularensis LVS infection. Macrophages require IFN-γ signaling to mediate protection, which ultimately results in recruitment of neutrophils to further aid in survival from infection.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  interferons; lung defense; lung infection; macrophages; neutrophils; tularemia

Mesh:

Substances:

Year:  2017        PMID: 28373354      PMCID: PMC5442621          DOI: 10.1128/IAI.00064-17

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  Nonacid-fast bacteria and HeLa cells: their uptake and subsequent intracellular growth.

Authors:  C C SHEPARD
Journal:  J Bacteriol       Date:  1959-06       Impact factor: 3.490

2.  Inflammatory monocytes but not neutrophils are necessary to control infection with Toxoplasma gondii in mice.

Authors:  Ildiko R Dunay; Anja Fuchs; L David Sibley
Journal:  Infect Immun       Date:  2010-02-09       Impact factor: 3.441

3.  Different host defences are required to protect mice from primary systemic vs pulmonary infection with the facultative intracellular bacterial pathogen, Francisella tularensis LVS.

Authors:  J Wayne Conlan; Rhonda KuoLee; Hua Shen; Ann Webb
Journal:  Microb Pathog       Date:  2002-03       Impact factor: 3.738

4.  Further insight into mechanism of action of clodronate: inhibition of mitochondrial ADP/ATP translocase by a nonhydrolyzable, adenine-containing metabolite.

Authors:  Petri P Lehenkari; Maarit Kellinsalmi; Juha P Näpänkangas; Kari V Ylitalo; Jukka Mönkkönen; Michael J Rogers; Alex Azhayev; H Kalervo Väänänen; Ilmo E Hassinen
Journal:  Mol Pharmacol       Date:  2002-05       Impact factor: 4.436

Review 5.  The live vaccine strain of Francisella tularensis replicates in human and murine macrophages but induces only the human cells to secrete proinflammatory cytokines.

Authors:  Courtney E Bolger; Colin A Forestal; Jaime K Italo; Jorge L Benach; Martha B Furie
Journal:  J Leukoc Biol       Date:  2005-03-09       Impact factor: 4.962

6.  Nitric oxide-independent killing of Francisella tularensis by IFN-gamma-stimulated murine alveolar macrophages.

Authors:  T Polsinelli; M S Meltzer; A H Fortier
Journal:  J Immunol       Date:  1994-08-01       Impact factor: 5.422

7.  Initial delay in the immune response to Francisella tularensis is followed by hypercytokinemia characteristic of severe sepsis and correlating with upregulation and release of damage-associated molecular patterns.

Authors:  Chris A Mares; Sandra S Ojeda; Elizabeth G Morris; Qun Li; Judy M Teale
Journal:  Infect Immun       Date:  2008-04-14       Impact factor: 3.441

Review 8.  Interleukin-12 and the regulation of innate resistance and adaptive immunity.

Authors:  Giorgio Trinchieri
Journal:  Nat Rev Immunol       Date:  2003-02       Impact factor: 53.106

9.  Adaptation of Francisella tularensis to the mammalian environment is governed by cues which can be mimicked in vitro.

Authors:  Karsten R O Hazlett; Seth D Caldon; Debbie G McArthur; Kerry A Cirillo; Girish S Kirimanjeswara; Micheal L Magguilli; Meenakshi Malik; Aaloki Shah; Scott Broderick; Igor Golovliov; Dennis W Metzger; Krishna Rajan; Timothy J Sellati; Daniel J Loegering
Journal:  Infect Immun       Date:  2008-07-21       Impact factor: 3.441

10.  Neutrophils are critical for host defense against primary infection with the facultative intracellular bacterium Francisella tularensis in mice and participate in defense against reinfection.

Authors:  A Sjöstedt; J W Conlan; R J North
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

View more
  11 in total

1.  Detrimental Influence of Alveolar Macrophages on Protective Humoral Immunity during Francisella tularensis SchuS4 Pulmonary Infection.

Authors:  Donald J Steiner; Yoichi Furuya; Dennis W Metzger
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

2.  Complement C3 as a Prompt for Human Macrophage Death during Infection with Francisella tularensis Strain SCHU S4.

Authors:  Susan R Brock; Michael J Parmely
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441

3.  Toll-Like Receptors 2 and 4 Modulate Pulmonary Inflammation and Host Factors Mediated by Outer Membrane Vesicles Derived from Acinetobacter baumannii.

Authors:  Chad R Marion; Jaewook Lee; Lokesh Sharma; Kyong-Su Park; Changjin Lee; Wei Liu; Pei Liu; Jingjing Feng; Yong Song Gho; Charles S Dela Cruz
Journal:  Infect Immun       Date:  2019-08-21       Impact factor: 3.441

4.  The Biosynthetic Pathway of Ubiquinone Contributes to Pathogenicity of Francisella novicida.

Authors:  Katayoun Kazemzadeh; Mahmoud Hajj Chehade; Gautier Hourdoir; Camille Dorothée Brunet; Yvan Caspar; Laurent Loiseau; Frederic Barras; Fabien Pierrel; Ludovic Pelosi
Journal:  J Bacteriol       Date:  2021-09-20       Impact factor: 3.490

5.  Aim2 and Nlrp3 Are Dispensable for Vaccine-Induced Immunity against Francisella tularensis Live Vaccine Strain.

Authors:  Meenakshi Malik; Chandra Shekhar Bakshi; Maha Alqahtani; Zhuo Ma; Kayla Fantone
Journal:  Infect Immun       Date:  2021-06-16       Impact factor: 3.441

6.  Francisella tularensis Confronts the Complement System.

Authors:  Susan R Brock; Michael J Parmely
Journal:  Front Cell Infect Microbiol       Date:  2017-12-19       Impact factor: 5.293

7.  An Improved Tobacco Mosaic Virus (TMV)-Conjugated Multiantigen Subunit Vaccine Against Respiratory Tularemia.

Authors:  Ahd A Mansour; Sukalyani Banik; Ragavan V Suresh; Hardeep Kaur; Meenakshi Malik; Alison A McCormick; Chandra S Bakshi
Journal:  Front Microbiol       Date:  2018-06-05       Impact factor: 5.640

8.  CD200R deletion promotes a neutrophil niche for Francisella tularensis and increases infectious burden and mortality.

Authors:  J Casulli; M E Fife; S A Houston; S Rossi; J Dow; E D Williamson; G C Clark; T Hussell; R V D'Elia; M A Travis
Journal:  Nat Commun       Date:  2019-05-09       Impact factor: 14.919

9.  Early infection-induced natural antibody response.

Authors:  Klara Kubelkova; Tomas Hudcovic; Hana Kozakova; Jaroslav Pejchal; Ales Macela
Journal:  Sci Rep       Date:  2021-01-15       Impact factor: 4.379

10.  Structural and functional analysis of the Francisella lysine decarboxylase as a key actor in oxidative stress resistance.

Authors:  Jan Felix; Claire Siebert; Julia Novion Ducassou; Jérôme Nigou; Pierre Simon Garcia; Angélique Fraudeau; Karine Huard; Caroline Mas; Céline Brochier-Armanet; Yohann Couté; Irina Gutsche; Patricia Renesto
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.